ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$55.71
-1.38 (-2.42%)
Open$57.11
Previous Close$57.09
Day High$57.12
Day Low$55.49
52W High$66.37
52W Low$14.27
Volume—
Avg Volume394.1K
Market Cap1.63B
P/E Ratio128.57
EPS$0.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
-78.6% upside
Current
$55.71
$55.71
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 85.76M | 55.14M | 122.17M |
| Net Income | -4,935,278 | -2,855,880 | 16.25M |
| Profit Margin | -5.8% | -5.5% | 13.3% |
| EBITDA | 3.43M | 2.10M | 25.36M |
| Free Cash Flow | — | — | 11.15M |
| Rev Growth | +55.5% | +55.5% | -8.5% |
| Debt/Equity | 1.17 | 1.17 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |